Subconjunctival and/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival. [electronic resource]
Producer: 20151117Description: 221-7 p. digitalISSN:- 1573-2630
- Adult
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Case-Control Studies
- Corneal Diseases -- surgery
- Corneal Neovascularization -- prevention & control
- Corneal Transplantation -- adverse effects
- Female
- Graft Rejection -- prevention & control
- Graft Survival
- Humans
- Injections, Intraocular
- Male
- Middle Aged
- Prospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.